Insider · CIK 0001257809
Frank McCormick
Files at BBIO (BridgeBio Pharma, Inc.), BBOT (BridgeBio Oncology Therapeutics, Inc.). First filing Jun 26, 2025, latest Sep 8, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | BridgeBio Pharma, Inc. | $3.9M 74,000 shares | -47% | +139% from low0% from high | |
| 40Moderate | BridgeBio Pharma, Inc. | $4.4M 100,000 shares | -10% | +99% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock | +74,000 | $11.92 | $882k | 157,275 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock | -74,000 | $53.16 | $3.9M | 83,275 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -74,000 | $0.00 | $0 | 84,814 | Sep 8, 2025 |
| Aug 26, 2025 | BBOT BridgeBio Oncology Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +91,076 | $0.00 | $0 | 91,076 | Aug 28, 2025 |
| Jun 24, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By the Francis P. McCormick Rev Trust U/A DTD 1/27/201710b5-1 | -100,000 | $44.23 | $4.4M | 879,979 | Jun 26, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +6,589 | $0.00 | $0 | 83 | Jun 24, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,425 | $0.00 | $0 | 8,425 | Jun 24, 2025 |
| May 7, 2025 | BBIO BridgeBio Pharma, Inc. | GGift Common Stock | -33,000 | $0.00 | $0 | 79,686 | May 9, 2025 |
| May 8, 2025 | BBIO BridgeBio Pharma, Inc. | GGift Common Stock | -3,000 | $0.00 | $0 | 76,686 | May 9, 2025 |
| Dec 26, 2024 | BBIO BridgeBio Pharma, Inc. | GGift Common Stock | -7,400 | $0.00 | $0 | 464,976 | Dec 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.